Cargando…
Sustained-Release Esketamine Based Nanoparticle-Hydrogel Delivery System for Neuropathic Pain Management
INTRODUCTION: Esketamine, one of the few non-opioid potent analgesics, has demonstrated efficacy in the treatment of various chronic pain, particularly neuropathic pain. However, its potential clinical applications are confined due to its short half-life and severe side effects including delirium, h...
Autores principales: | Zhang, Hao, Zhou, Ping, Jiang, Yi, Li, Liu, Ju, Fei, Cheng, Quan, Zhou, You Lang, Zhou, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007983/ https://www.ncbi.nlm.nih.gov/pubmed/36915698 http://dx.doi.org/10.2147/IJN.S400798 |
Ejemplares similares
-
Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery
por: Courtenay, Aaron J., et al.
Publicado: (2020) -
Silk Fibroin Hydrogel Reinforced With Magnetic Nanoparticles as an Intelligent Drug Delivery System for Sustained Drug Release
por: Haghighattalab, Mahsa, et al.
Publicado: (2022) -
Sustained-release pregabalin with methylcobalamin in neuropathic pain: an Indian real-life experience
por: Dongre, Yasmin U, et al.
Publicado: (2013) -
Epidural Sustained Release Ropivacaine Prolongs Anti-Allodynia and Anti-Hyperalgesia in Developing and Established Neuropathic Pain
por: Li, Teng-Fei, et al.
Publicado: (2015) -
Preclinical Evaluation of Polymeric Nanocomposite Containing Pregabalin for Sustained Release as Potential Therapy for Neuropathic Pain
por: Rodrigues, Rafaela Figueiredo, et al.
Publicado: (2021)